Commentary Open Access
Volume 4 | Issue 1 | DOI: https://doi.org/10.46439/aging.4.020
P38 molecular targeting for next-generation kidney damage therapy
Jinghong Zhao1, Jun Gu2,*
- 1Department of Nephrology, Chongqing Key Laboratory of Prevention and Treatment of Kidney Disease, Chongqing Clinical Research Center of Kidney and Urology Diseases, Xinqiao Hospital, Army Medical University (Third Military Medical University), Chongqing 400037, China
- 2State Key Laboratory of Protein and Plant Gene Research, College of Life Science, Peking University, Beijing100871, China
Corresponding Author
Jun Gu, gj@pku.edu.cn
Received Date: July 01, 2024
Accepted Date: August 16, 2024
Zhao J, Gu J. P38 molecular targeting for next-generation kidney damage therapy. Am J Aging Sci Res. 2024;4(1):18-21.
Copyright: © 2024 Zhao J, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Recommended Articles
Effect of acute low oxygen exposure on the proliferation rate, viability and myogenic regulatory gene expression of C2C12 myoblasts in vitro
Within human tissue, oxygen concentrations are considerably less than the 21% O2 concentrations found in ambient air and is termed physiological hypoxia. Typically, the partial pressure of oxygen
(pO2) of human tissue lies between 1% and 14%, with considerable local and regional variations
Coal workers' serum immunoglobulins provide hints for pneumoconiosis
Today, roughly 30% of the global energy needs are met by coal, according to the International Energy Agency. Over the past few decades, although many measures have been taken to protect workers against dust inhalation, coal workers’ pneumoconiosis (CWP) remains to be a significant threat to public health, especially in developing countries. Data from the global burden of disease (GBD) study showed that the number of pneumoconiosis cases increased by 66.0% from 1990 to 2017, reaching 60,000.
Usefulness to assess the disease progression and mortality risk profiles, in a population of chronic kidney disease patients followed by general practitioners and nephrologists
The number of individuals with all-stage chronic kidney disease (CKD) reached almost 700 million in 2017, which is more people than those with diabetes, osteoarthritis, chronic obstructive pulmonary disease (COPD), asthma, or depressive disorders [1]. A multitude of studies have been published in the field of CKD based on patho-physiological considerations, screening, etiological factors, clinical observations, targeted therapeutic interventions, but very little is known about the fate of a patient, who has CKD and who is followed for years by his treating physician and the reference nephrologist.
Analysis of chronic kidney disease on diagnosis, treatment, prognosis and related risk factors in patients with lymphoma: A mini-review
Currently, the field of tumor nephrology continues to evolve, and the interplay between chronic kidney disease (CKD) and lymphoma merits further investigation. The incidence of CKD among lymphoma patients is substantial, posing a significant long-term risk for CKD progression. CKD should be regarded as an independent prognostic factor for mortality in lymphoma patients. In this mini-review, we aim to extend the research direction outlined in "Diagnosis and Treatment of Secondary Nephrotic Syndrome with Rash as the Initial Symptom: A Case Report", with a focus on elucidating the correlation between CKD and lymphoma.
Association of fundus damage, renal function deterioration, and ferroptosis in chronic kidney disease patients
Introduction: This study aimed to explore the changes in ferroptosis markers and their relationship with fundus lesion severity in chronic kidney disease (CKD). Methods: We enrolled 118 CKD patients and collected clinical, renal function, fundus imaging data, and ferroptosis markers. We performed correlation and regression analyses between renal dysfunction and fundus lesions, and assessed the changes and mediating roles of serum iron (Fe), malondialdehyde (MDA), and reduced glutathione (GSH) in CKD deterioration and retinal damage.